Intervention Protocol

You have full text access to this OnlineOpen article

Idarubicin compared to other anthracyclines for treatment of newly diagnosed acute myeloid leukaemia

  1. Xi Li,
  2. ShuangNian Xu,
  3. Ya Tan,
  4. JiePing Chen*

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 28 MAR 2013

DOI: 10.1002/14651858.CD010432

How to Cite

Li X, Xu S, Tan Y, Chen J. Idarubicin compared to other anthracyclines for treatment of newly diagnosed acute myeloid leukaemia (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD010432. DOI: 10.1002/14651858.CD010432.

Author Information

  1. Southwest Hospital, Third Military Medical University, Center for Hematology, Chongqing, China

*JiePing Chen, Center for Hematology, Southwest Hospital, Third Military Medical University, 38 Gao Tanyan Street, Chongqing, 400038, China. chenjpxn@yahoo.com.cn.

Publication History

  1. Publication Status: New
  2. Published Online: 28 MAR 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the efficacy and safety of IDA versus other anthracyclines in induction therapy of newly diagnosed AML patients.